Skip to main content
Advertisement
  • Other Publications
    • EMBO Press
    • EMBO reports (Home)
    • The EMBO Journal
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Life Science Alliance
Login

   

Search

Advanced Search

Journal

  • Home
  • Latest Online
  • Current Issue
  • Archive
  • Subject Collections
  • Review Series & Focuses

Authors & Referees

  • Submit
  • Author Guidelines
  • Aims & Scope
  • Editors & Board
  • Transparent Process
  • Bibliometrics
  • Referee Guidelines
  • Open Access

Info

  • E-Mail Editorial Office
  • Alerts
  • RSS Feeds
  • Subscriptions & Access
  • Reprints & Permissions
  • Advertise & Sponsor
  • Media Partners
  • News & Press
  • Recommend to Librarian
  • Customer Service
  • Home
  • EMBO reports: 19 (4)

Science & Society

Personalized medicine and proper dosage

Over‐ and undertreatment of chronic diseases endanger patients’ health and strain public health systems
Anthi Trasta
DOI 10.15252/embr.201845957 | Published online 27.02.2018
EMBO reports (2018) 19, e45957
Anthi Trasta
Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Author Affiliations

  1. Anthi Trasta (trasta{at}embl.de)1
  1. 1 Heidelberg, Germany
View Abstract
  • Article
  • Transparent Process
Loading

Overtreatment and undertreatment of common medical conditions—such as diabetes mellitus, hypertension, or hypercholesterolemia—has become a major global health problem [1], [2], [3]. The past years have seen an—often unjustified—increased use of glucose‐, lipid‐, and blood pressure‐lowering medications that is straining public healthcare systems with unnecessary costs. At the same time, “clinical inertia”, namely a failure to initiate or intensify therapy, creates avoidable health risks for patients.

Overtreatment is particularly problematic for elderly patients with several medical conditions.

Of these, undertreatment is much more dangerous as it contributes to the increasing incidence of common, chronic diseases. “Clearly, patients with significant disease should be treated when evidence indicates a possible benefit”, commented Daniel Morgan, Associate Professor of Epidemiology and Public Health and Medicine at the University of Maryland. “If we undertreat populations with diabetes and hypertension, we are likely to see increased cardiac and vascular disease”.

Overtreatment is a public health problem

But overtreatment has serious consequences, too. Glucose‐lowering medications to treat diabetes have been blamed for up to 25% of emergency hospitalizations in the USA to treat hypoglycemia [3]. Diabetic treatments have also been implicated in cardiovascular events, cognitive impairment, fractures, and death [4]. Aggressive hypertension treatments often cause hypotension with potentially severe side effects, including acute renal failure, hyponatremia, hypokalemia, and syncope [1]. Statins to treat hypercholesterolemia also have numerous side effects: high blood glucose, which increases the risk for diabetes, abnormal liver enzyme levels, and muscle pain or—more rarely—muscle damage. “The outcomes of potential overtreatment for the individual and public health are enormous”, commented Elbert Huang, Director of the Center for Translational and Policy Research of Chronic Diseases and Associate Director of the Chicago Center for Diabetes Translation Research at the University of Chicago, IL, USA. “Patients are exposed to the unnecessary risks …

View Full Text

Subscribers, please sign in with your username and password.

Log in using your username and password

Enter your EMBO Reports username.
Enter the password that accompanies your username.
Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

EMBO Members please login here to access the journals

Subscribe to the Journal

EMBO Journal

EMBO Reports

Recommend to your Librarian

EMBO Journal

EMBO Reports

 

 

Previous Article in this IssueNext Article in this Issue
Back to top

  • PDF
  • Share
  • Export
  • Print
Loading

PDF

In this Issue
Volume 19, Issue 4
01 April 2018 | pp -
EMBO reports: 19 (4)
About the cover
Alert me when this article is cited
Alert me if a correction is posted

Article

  • Article
    • Overtreatment is a public health problem
    • Multiple causes of mistreatment
    • Addressing the problem
    • An argument for personalized medicine
    • References
  • Transparent Process

Related Content

More Science & Society

  • Improving animal research reporting standards
    Nikki Osborne, Marc T Avey, Lida Anestidou, Merel Ritskes‐Hoitinga, Gilly Griffin
    EMBO reports : e46069
  • Science, politics and ideologies
    Philip Hunter
    EMBO reports : e46130
  • Synthetic gene drive: between continuity and novelty
    Samson Simon, Mathias Otto, Margret Engelhard
    EMBO reports : e45760
More Science & Society

Related Articles

Cited By...

Request Permissions

Subject Areas

  • S&S: Health & Disease
  • S&S: Politics, Policy & Law

Journal

  • Latest Online
  • Current Issue
  • Archive
  • Bibliometrics
  • E-Mail Editorial Office

Authors & References

  • Aims & Scope
  • Editors & Board
  • Transparent Process
  • Author Guidelines
  • Referee Guidelines
  • Open Access
  • Submit

Info

  • Alerts
  • RSS Feeds
  • Subscriptions & Access
  • Reprints & Permissions
  • Advertise & Sponsor
  • News & Press
  • Recommend to Librarian
  • Customer Service

EMBO

  • Funding & Awards
  • Events
  • Science Policy
  • Members
  • About EMBO

Online ISSN  1469-3178

Copyright© 2018 EMBO

This website is best viewed using the latest versions of all modern web browsers. Older browsers may not display correctly.